These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 6599674)

  • 41. Role of central vasopressin in cardiovascular regulation.
    Berecek KH
    J Cardiovasc Pharmacol; 1986; 8 Suppl 7():S76-80. PubMed ID: 2434778
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of a selective V1 vasopressin receptor antagonist on the sequelae of endotoxemia in the conscious rat.
    Egan JW; Jugus M; Kinter LB; Lee K; Smith EF
    Circ Shock; 1989 Oct; 29(2):155-66. PubMed ID: 2684446
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Vascular binding sites and biological activity of vasopressin in DOCA-salt hypertensive rats.
    Larivière R; St-Louis J; Schiffrin EL
    J Hypertens; 1988 Mar; 6(3):211-7. PubMed ID: 3283226
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of acute vasopressin infusion on blood pressure and plasma angiotensin II in normotensive and DOCA-salt hypertensive rats.
    Morton JJ; Garcia del Rio C; Hughes MJ
    Clin Sci (Lond); 1982 Feb; 62(2):143-9. PubMed ID: 7053914
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Vasopressin and sympathetic nervous functions both contribute to development and maintenance of hypertension in DOCA-salt rats.
    Takata Y; Yamashita Y; Takishita S; Fujishima M
    Clin Exp Hypertens A; 1988; 10(2):203-27. PubMed ID: 3370846
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Withdrawal-induced antihypertensive effect of vasopressin in Doca-salt hypertension.
    Chiu EK; McNeill JR
    Am J Hypertens; 1989 Jun; 2(6 Pt 1):458-61. PubMed ID: 2757802
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Microvascular vasopressin effects during endotoxin shock in the rat.
    Baker CH; Sutton ET; Zhou Z; Dietz JR
    Circ Shock; 1990 Feb; 30(2):81-95. PubMed ID: 2178794
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Central mechanisms in DOC-salt hypertensive rats.
    Matsuguchi H; Sharabi FM; O'Connor G; Mark AL; Schmid PG
    Clin Exp Hypertens A; 1982; 4(8):1303-21. PubMed ID: 7116668
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Renal function contributes to antihypertensive effect of vasopressin in DOCA-salt but not spontaneous hypertension.
    Wang H; McNeill JR
    Am J Physiol; 1994 Nov; 267(5 Pt 2):H1842-50. PubMed ID: 7977814
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Role of AVP in malignant DOC-salt hypertension: studies using vascular and antidiuretic antagonists.
    Filep J; Frölich JC; Földes-Filep E
    Am J Physiol; 1987 Nov; 253(5 Pt 2):F952-8. PubMed ID: 3688242
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sensitization to pressor effects by repeated central injections of vasopressin in conscious rats.
    Lebrun CJ; Rohmeiss P; Demmert G; Unger T
    Brain Res; 1989 Dec; 505(1):39-43. PubMed ID: 2611677
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Central catecholamine depletion, vasopressin, and blood pressure in the DOCA/NaCl rat.
    Okuno T; Winternitz SR; Lindheimer MD; Oparil S
    Am J Physiol; 1983 Jun; 244(6):H807-13. PubMed ID: 6407335
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mechanism for the cardiovascular action of intracerebroventricularly administered vasoactive intestinal polypeptide in rats.
    Endo M; Arita J; Fujita K; Kimura F
    Exp Clin Endocrinol; 1991 Mar; 97(1):55-62. PubMed ID: 1864314
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Differential actions of neuronal and hormonal vasopressin on blood pressure and baroreceptor reflex sensitivity in rats.
    Unger T; Rohmeiss P; Demmert G; Luft FC; Ganten D; Lang RE
    J Cardiovasc Pharmacol; 1986; 8 Suppl 7():S81-6. PubMed ID: 2434779
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cardiovascular effects of thyrotropin-releasing hormone in normotensive and hypotensive rats: role of rostral ventrolateral medulla.
    Yan J; Chen H; Liao W; Lu S
    Circ Shock; 1992 Jul; 37(3):253-61. PubMed ID: 1423917
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Central effects of somatostatin: pressor response, AVP release, and sympathoinhibition.
    Rettig R; Geist R; Sauer U; Rohmeiss P; Unger T
    Am J Physiol; 1989 Sep; 257(3 Pt 2):R588-94. PubMed ID: 2571303
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Microinjection of vasopressin into the locus coeruleus of conscious rats.
    Berecek KH; Olpe HR; Jones RS; Hofbauer KG
    Am J Physiol; 1984 Oct; 247(4 Pt 2):H675-81. PubMed ID: 6496709
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vasopressinase-altered vasopressin elevates arterial pressure in anesthetized rats.
    Krege JH; Faber JE; Klapper DG; Katz VL; Colindres RE
    Am J Perinatol; 1993 Mar; 10(2):160-3. PubMed ID: 8476482
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Central vasopressin impairs the baroreceptor heart rate reflex in conscious rats.
    Brattström A; de Jong W; De Wied D
    J Cardiovasc Pharmacol; 1990 Jan; 15(1):114-7. PubMed ID: 1688967
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Involvement of vasopressin in the cardiovascular effects of intracerebroventricularly administered alpha 1-adrenoceptor agonists in the conscious rat.
    Hiwatari M; Johnston CI
    J Hypertens; 1985 Dec; 3(6):613-20. PubMed ID: 2868056
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.